Patent ID: 11878000
Assignee: DA ZEN THERANOSTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The method of claim 1, comprising administering one or more combination selected from the group consisting of:
Gefitinib in combination with a DZ1-SIM ester sensitizer;
Gefitinib in combination with a DZ1-SIM amide sensitizer;
Gefitinib in combination with a DZ1-CIS ester sensitizer;
Gefitinib in combination with a DZ1-CIS amide sensitizer;
Gefitinib in combination with a DZ1-ART ester sensitizer;
Gefitinib in combination with a DZ1-ART amide sensitizer.